An Entry-Triggering Protein of Ehrlichia Is a New Vaccine Candidate against Tick-Borne Human Monocytic Ehrlichiosis

An Entry-Triggering Protein of Ehrlichia Is a New Vaccine Candidate against Tick-Borne Human Monocytic Ehrlichiosis

The incidence of tick-borne diseases has risen dramatically in the past two decades and continues to rise. Discovered in 1986 and designated a nationally notifiable disease in 1998 by the Centers for Disease Control and Prevention, human monocytic ehrlichiosis, which is caused by the bacterium Ehrli...

Full description

Bibliographic Details
Main Authors: Khemraj Budachetri, Omid Teymournejad, Mingqun Lin, Qi Yan, Mariella Mestres-Villanueva, Guy Nathaniel Brock, Yasuko Rikihisa
Format: Article
Language:English
Published: American Society for Microbiology 2020-07-01
Series:mBio
Subjects:
ehrlichia chaffeensis
etpe
iscom
interferon gamma
dogs
human monocytic ehrlichiosis
immunization
neutralizing antibodies
tick cells
tick-borne pathogens
Online Access:https://doi.org/10.1128/mBio.00895-20

Internet

https://doi.org/10.1128/mBio.00895-20

Similar Items